Are Systen 50 patches safe after treatment of tri-negative breast cancer and removal of the uterus and ovaries?
* required field
* required field
Suggested Products
Space for your product
Angelika Talar-Śpionek Pharmacist, Editor
2 years ago
According to the manufacturer's data contained in the Safety Data Sheet Systen 50, the use of the drug is contraindicated, m.in. in patients diagnosed with breast cancer. Therefore, before starting a possible course of treatment, it would be best to consult a doctor again. If you do not have the opportunity to consult your gynecologist, you can use the teleadvice here: https://www.gdziepolek.pl/telekonsultacja/z-ginekologiem